Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation

Published:2006-06-21 Issue:1 Volume:38 Page:53-60
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Lengerke C,Ljubicic T,Meisner C,Loeffler J,Sinzger C,Einsele H,Hebart H

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705408.pdf

Reference49 articles.

1. Emmanuel D, Cunningham L, Jules-Elysee K, Brochstein JA, Kernan NA, Laver J et al. Cyomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777–782.

2. Ljungman P, Aschan J, Lewensohn-Fuchs I, Carlens S, Larsson K, Lonnqvist B et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell recipients. Transplantation 1998; 66: 1330–1334.

3. Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human bone marrow transplantation. J Infect Dis 1998; 153: 478–488.

4. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD, Reed EC et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplantation. Ann Intern Med 1988; 109: 783–788.

5. Goodrich JM, Boeckh M, Bowden R . Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clin Infect Dis 1994; 19: 287–298.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selecting the best haploidentical donor;Seminars in Hematology;2016-10

2. Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients;Journal of Clinical Virology;2015-08

3. Organ-specific management and supportive care in chronic graft-versus-host disease;British Journal of Haematology;2012-04-26

4. Effective Use of PCR for the Detection of Cytomegalovirus Viremia and Monitoring Therapy in Immunocompromised Patients;LABMEDICINE;2011

5. Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation;Journal of Medical Virology;2011-01-24